MEMPHIS, Tenn., May 4, 2017 /PRNewswire/ -- Poplar Healthcare, a leading laboratory services company headquartered in Memphis, TN, announced today that it has completed the acquisition of substantially all of the assets of Bostwick Laboratories, a specialty anatomic pathology laboratory focused on the diagnosis of cancer.
Bostwick Laboratories is a leader in urologic pathology with expertise and a growing presence in the dermatology, gastroenterology, gynecology, and nephrology sectors of the anatomic pathology market. Poplar Healthcare has acquired all of the operating assets of Bostwick Laboratories including the customers, inventory, and equipment at Bostwick Laboratories facilities in Uniondale, New York; Orlando, Florida; and Glen Allen, Virginia.
"We have admired Bostwick Laboratories for many years and are pleased to add the Bostwick Laboratories brand to our sub-specialized pathology service offering," said Poplar Healthcare CEO James Sweeney. "Dr. David Bostwick is a leading expert in urologic pathology and laboratory science. We look forward to working with him and his entire team to leverage the best of both companies. We are also eager to serve Bostwick Laboratories' long-standing customers and will continue to provide them with expert pathology services."
Through this transaction, Bostwick Laboratories will gain access to additional markets and health plans. As an in-network laboratory service provider to most major insurance carriers and health plans, Poplar Healthcare will provide expanded access to Bostwick Laboratories' patients. Bostwick customers will receive access to an expanded menu of tests and services via Poplar Healthcare's extensive menu of molecular testing services which will be available through Bostwick Laboratories. In addition, Poplar Healthcare will gain a leading renal pathology laboratory and additional sub-specialized pathologists.
About Poplar Healthcare
Founded in 1995 and headquartered in Memphis, Tennessee, Poplar Healthcare is a leading laboratory services company. Through its GI Pathology, D-PATH, OncoMetrix, UroPathDx and Women's Health Laboratories brands, Poplar Healthcare provides specialized laboratory testing services to a nationwide client base of gastroenterologists, dermatologists, oncologists, urologists, gynecologists and their patients. For more information visit poplarhealthcare.com.
About Bostwick Laboratories
Bostwick Laboratories is a CAP accredited anatomic pathology laboratory specializing in the monitoring and diagnosis of cancer. Bostwick Laboratories is the leading referral laboratory for prostate and urologic biopsies. Bostwick Laboratories also has expertise and a growing presence in the dermatology, gastroenterology, gynecology, and nephrology sectors of the anatomic pathology market. For more information visit bostwicklaboratories.com.
Contact: Beth Okeon
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/poplar-healthcare-acquires-bostwick-laboratories-300451820.html
SOURCE Poplar Healthcare